Dissolved and financials
CVR: 36701676
Previous names: BioLife BioTech ApS
DKK 520,019
Gross profit
Net result: DKK -10,407
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 23 February 2022
CVR · view overview
1 employee
CVR · 2021
Director role ended: Lotte Bjørg Strøbech
CVR · 23/02/2022
View the full event history
EmbryoTrans Biotech ApS was a Danish company of the type Anpartsselskab based in Hundested, founded in 2015. The company has been dissolved on 23 February 2022. The company was registered under the industry Detailhandel med medicinske og ortopædiske artikler. The company was previously named BioLife BioTech ApS. The company has 1 employee (2021). In 2020, the company reported a gross profit of DKK 520,019 and a net result of DKK -10,407 compared with DKK 23,111 the year before. Equity in the 2020 report amounted to DKK 242,326.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202001/01/2020 – 31/12/2020 | 520 t. | -10 t. | 358 t. | 242 t. | 2 | |
| 201901/01/2019 – 31/12/2019 | 1.3 mio. | 23 t. | 498 t. | 253 t. | 2 | |
| 201801/01/2018 – 31/12/2018 | 1.1 mio. | -18 t. | 745 t. | 260 t. | - | |
| 201701/01/2017 – 31/12/2017 | 1.8 mio. | 172 t. | 1.3 mio. | 377 t. | - | |
| 201601/01/2016 – 31/12/2016 | 1.8 mio. | 132 t. | 838 t. | 455 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringNo. EmbryoTrans Biotech ApS is registered in the Danish CVR register with the status Dissolved and ceased on 23 February 2022.
The CVR number of EmbryoTrans Biotech ApS is 36701676.
In 2020, EmbryoTrans Biotech ApS reported a gross profit of DKK 520,019.
EmbryoTrans Biotech ApS had 1 employee in 2021 according to the Danish CVR register.
EmbryoTrans Biotech ApS was founded on 22 March 2015.
EmbryoTrans Biotech ApS was registered under the industry Detailhandel med medicinske og ortopædiske artikler (industry code 477400).
As of February 23, 2022, Lotte Bjørg Strøbech has left the board of directors of EmbryoTrans Biotech ApS.
As of February 23, 2022, Lotte Bjørg Strøbech has stepped down as director of EmbryoTrans Biotech ApS.
As of February 23, 2022, Ulrik Bangsbo Hansen has stepped down as chairman of EmbryoTrans Biotech ApS.
EmbryoTrans Biotech ApS was dissolved on February 23, 2022.
EmbryoTrans Biotech ApS has published its annual report for 2020. Gross profit came to DKK 520,019, and the net result was DKK -10,407.
EmbryoTrans Biotech ApS has published its annual report for 2019. Gross profit came to DKK 1,319,977, and the net result was DKK 23,111.
EmbryoTrans Biotech ApS has published its annual report for 2018. Gross profit came to DKK 1,135,620, and the net result was DKK -17,779.
EmbryoTrans Biotech ApS has published its annual report for 2017. Gross profit came to DKK 1,838,431, and the net result was DKK 172,405.
EmbryoTrans Biotech ApS has published its annual report for 2016. Gross profit came to DKK 1,767,468, and the net result was DKK 132,445.
EmbryoTrans Biotech ApS has published its interim report for the period March 23, 2015 to December 31, 2015.
As of February 26, 2016, Lotte Bjørg Strøbech has joined the board of directors of EmbryoTrans Biotech ApS.
As of February 26, 2016, Ulrik Bangsbo Hansen is registered as chairman of EmbryoTrans Biotech ApS.
As of September 17, 2015, Bjarne Jørnsgård has left the board of directors of EmbryoTrans Biotech ApS.
As of September 17, 2015, Lotte Bjørg Strøbech has left the board of directors of EmbryoTrans Biotech ApS.
As of September 17, 2015, Trine Hastrup has stepped down as chairman of EmbryoTrans Biotech ApS.
On April 18, 2015, the company changed its name from BioLife BioTech ApS to EmbryoTrans Biotech ApS.
As of March 23, 2015, Bjarne Jørnsgård has joined the board of directors of EmbryoTrans Biotech ApS.
As of March 23, 2015, Lotte Bjørg Strøbech has joined the board of directors of EmbryoTrans Biotech ApS.
As of March 23, 2015, Trine Hastrup is registered as chairman of EmbryoTrans Biotech ApS.
As of March 23, 2015, Lotte Bjørg Strøbech is registered as director of EmbryoTrans Biotech ApS.
EmbryoTrans Biotech ApS was founded on March 22, 2015.
Companies in the same industry and area
CVR 39593874
CVR 36917881
CVR 18800179
CVR 26987482
CVR 20025735
